303 related articles for article (PubMed ID: 24003303)
1. Current and emerging treatment options for uveal melanoma.
Pereira PR; Odashiro AN; Lim LA; Miyamoto C; Blanco PL; Odashiro M; Maloney S; De Souza DF; Burnier MN
Clin Ophthalmol; 2013; 7():1669-82. PubMed ID: 24003303
[TBL] [Abstract][Full Text] [Related]
2. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma.
Mallone F; Sacchetti M; Lambiase A; Moramarco A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992823
[TBL] [Abstract][Full Text] [Related]
3. [The clinical observation of external scleral plaque radiotherapy in patients with uveal melanoma].
Liu YM; Zhou N; Wei WB; Wang P
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):670-675. PubMed ID: 32907299
[No Abstract] [Full Text] [Related]
4. Solitary Metastases Presentation from Uveal Melanoma: Report of 3 Cases and a Comprehensive Review of the Literature.
Pereira PM; Luís A; Passos MJ; Gouveia E
Ocul Oncol Pathol; 2023 Feb; 8(4-6):203-210. PubMed ID: 36925729
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of liver metastasis with uveal melanoma: A case report.
Kim YH; Choi NK
World J Clin Cases; 2021 Oct; 9(28):8498-8503. PubMed ID: 34754859
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm.
Sayan M; Mamidanna S; Oncel D; Jan I; Vergalasova I; Weiner J; Ohri N; Acikalin B; Chundury A
Radiat Oncol J; 2020 Sep; 38(3):162-169. PubMed ID: 33012143
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy.
Fadel CA; Kanakamedala S; Danak SU; Johnson AT
Cureus; 2022 Jun; 14(6):e26146. PubMed ID: 35891820
[TBL] [Abstract][Full Text] [Related]
8. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
Goh AY; Layton CJ
Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
[TBL] [Abstract][Full Text] [Related]
9. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
10. New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review.
Toro MD; Gozzo L; Tracia L; Cicciù M; Drago F; Bucolo C; Avitabile T; Rejdak R; Nowomiejska K; Zweifel S; Yousef YA; Nazzal R; Romano GL
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680428
[TBL] [Abstract][Full Text] [Related]
11. Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling.
Wang MM; Chen C; Lynn MN; Figueiredo CR; Tan WJ; Lim TS; Coupland SE; Chan ASY
Front Mol Biosci; 2020; 7():611584. PubMed ID: 33585560
[TBL] [Abstract][Full Text] [Related]
12. [What else can we do for uveal melanoma].
Li B; Xu XL
Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
[TBL] [Abstract][Full Text] [Related]
13. Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology.
Vivet-Noguer R; Tarin M; Roman-Roman S; Alsafadi S
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330784
[TBL] [Abstract][Full Text] [Related]
14. [Management of uveal melanomas, guidelines for oncologists].
Mathis T; Cassoux N; Tardy M; Piperno S; Gastaud L; Dendale R; Maschi C; Nguyen AM; Meyer L; Bonnin N; Baillif S; Tick S; Mouriaux F; Jaspart F; Dellis J; Rosier L; Desjardins L; Herault J; Caujolle JP; Thariat J
Bull Cancer; 2018 Oct; 105(10):967-980. PubMed ID: 30217336
[TBL] [Abstract][Full Text] [Related]
15. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.
Klisovic DD; Klisovic MI; Effron D; Liu S; Marcucci G; Katz SE
Melanoma Res; 2005 Jun; 15(3):147-53. PubMed ID: 15917695
[TBL] [Abstract][Full Text] [Related]
16. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
17. Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?
Schiffner S; Braunger BM; de Jel MM; Coupland SE; Tamm ER; Bosserhoff AK
Exp Eye Res; 2014 Oct; 127():59-68. PubMed ID: 25051141
[TBL] [Abstract][Full Text] [Related]
18. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
19. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
20. [Orbital Exenteration in Patient with Metastatic Choroidal Melanoma - a Case Report].
Justusová P; Štubňa M; Veselovský M; Lipková B
Cesk Slov Oftalmol; 2016; 72(3):92-96. PubMed ID: 27658977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
